NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and KPL have signed a non-exclusive agreement giving KPL global rights to use Thermo’s DyLight Fluorescent Dyes in combination with KPL’s line of antibodies and proteins.
 
The antibodies and dyes can be used in a variety of life science research applications including fluorescence microscopy, Western blotting, and flow cytometry. KPL said it is expanding its offering of DyLight conjugates later this year using a complete series of DyLight dyes across the visible spectrum.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.